JP2025512923A5 - - Google Patents
Info
- Publication number
- JP2025512923A5 JP2025512923A5 JP2024558408A JP2024558408A JP2025512923A5 JP 2025512923 A5 JP2025512923 A5 JP 2025512923A5 JP 2024558408 A JP2024558408 A JP 2024558408A JP 2024558408 A JP2024558408 A JP 2024558408A JP 2025512923 A5 JP2025512923 A5 JP 2025512923A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- antigen
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263325330P | 2022-03-30 | 2022-03-30 | |
| US63/325,330 | 2022-03-30 | ||
| PCT/US2023/065017 WO2023192842A2 (en) | 2022-03-30 | 2023-03-28 | Anti-psma antibodies, variants, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512923A JP2025512923A (ja) | 2025-04-22 |
| JP2025512923A5 true JP2025512923A5 (https=) | 2026-02-18 |
Family
ID=88203394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024558408A Pending JP2025512923A (ja) | 2022-03-30 | 2023-03-28 | 抗ｐｓｍａ抗体、バリアント、及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250236680A1 (https=) |
| EP (1) | EP4499709A2 (https=) |
| JP (1) | JP2025512923A (https=) |
| KR (1) | KR20240164784A (https=) |
| CN (1) | CN118974097A (https=) |
| WO (1) | WO2023192842A2 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010507594A (ja) * | 2006-10-20 | 2010-03-11 | シェーリング コーポレイション | 完全ヒト抗ｖｅｇｆ抗体および使用方法 |
| BR112018070948A2 (pt) * | 2016-04-13 | 2019-01-29 | Orimabs Ltd. | anticorpos anti-psma e utilização dos mesmos |
| US11339218B2 (en) * | 2017-05-10 | 2022-05-24 | Zhejiang Shimai Pharmaceutical Co., Ltd. | Human monoclonal antibodies against LAG3 and uses thereof |
-
2023
- 2023-03-28 US US18/852,661 patent/US20250236680A1/en active Pending
- 2023-03-28 CN CN202380024354.7A patent/CN118974097A/zh active Pending
- 2023-03-28 KR KR1020247033524A patent/KR20240164784A/ko active Pending
- 2023-03-28 JP JP2024558408A patent/JP2025512923A/ja active Pending
- 2023-03-28 EP EP23782001.4A patent/EP4499709A2/en active Pending
- 2023-03-28 WO PCT/US2023/065017 patent/WO2023192842A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6866294B2 (ja) | 抗ｐｄ−ｌ１抗体 | |
| JP6701213B2 (ja) | 抗ｐｄ−１抗体 | |
| JP6127043B2 (ja) | Ａｇｒ２遮断抗体及びその使用 | |
| US20200079869A1 (en) | Anti-CD47 monoclonal antibody and use thereof | |
| JP6875275B2 (ja) | Ｌ１ｃａｍ（ｃｄ１７）と結合する抗体などの結合分子 | |
| JP2019516348A (ja) | 重症熱性血小板減少症候群ウイルスの外膜糖タンパク質に結合する抗体及びその用途 | |
| CN111148759B (zh) | 结合至纤维连接蛋白b结构域的蛋白 | |
| JP2024531409A5 (https=) | ||
| CN105209493A (zh) | 用于诊断和治疗用途的her3特异性单克隆抗体 | |
| US20250257130A1 (en) | Anti-ror1 antibodies | |
| WO2021047386A1 (zh) | 靶向caix抗原的纳米抗体及其应用 | |
| WO2023125842A1 (zh) | 一种新型upar单域抗体的开发 | |
| CN109879966B (zh) | 基于鼠源cd19抗体的人源化设计及表达验证 | |
| CN118754989B (zh) | 一种抗her2纳米抗体及其制备方法和应用 | |
| CN116265486A (zh) | 结合人cd73的抗体、其制备方法和用途 | |
| CN104861068B (zh) | 一种全人源抗her3抗体及其治疗相关疾病的用途 | |
| JP2025512923A5 (https=) | ||
| TW202413422A (zh) | 抗體、其抗原結合片段及其藥物用途 | |
| US20220089727A1 (en) | Anti-CD47 monoclonal antibody and use thereof | |
| CN109593134B (zh) | 抗cd20的人源化单克隆抗体及其制剂 | |
| CN110872356B (zh) | 双特异性抗体及其使用方法 | |
| CN120040594B (zh) | 一种靶向flt3基因编辑通用型car-t细胞的制备方法和应用 | |
| WO2024131846A1 (en) | Antibody, antigen-binding fragment thereof, and pharmaceutical use thereof | |
| CN114685670A (zh) | Cldn18.2抗体及其应用 | |
| CN115785269B (zh) | 抗pd-l1的抗体及其应用 |